The Journal of Pediatrics
Volume 151, Issue 6 , Pages 561-563 , December 2007

Staphylococcus Aureus: A Moving Target

  • Arthur L. Frank, MD

      Affiliations

    • Corresponding Author InformationReprint requests: Arthur L. Frank, MD, Department of Pediatrics MC 856, University of Illinois at Chicago, 840 S Wood St, Chicago IL 60612.

References 

  1. Faden H, Rose R, Lesse A, Hollands C, Dryja D, Glick PL. Clinical and molecular characteristics of staphylococcal skin abscesses in children. J Pediatr. 2007;151:700–703
  2. Daum RS. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007;357:380–390
  3. Chambers HF. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis. 2001;7:178–182
  4. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998;279:593–598
  5. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus— Minnesota and North Dakota, 1997-1999. MMWR. 1999;48:707–710
  6. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol. 2003;41:5113–5120
  7. Diep BA, Gill SR, Chang RF, Phan TH, Chen JH, Davidson MG, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet. 2006;367:731–739
  8. Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, et al. Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas. Antimicrob Agents Chemo. 2005;49:2283–2288
  9. Stemper ME, Brady JM, Qutaishat SS, Borlaug G, Reed J, Reed KD, et al. Shift in Staphylococcus aureus clone linked to an infected tattoo. Emerg Infect Dis. 2006;12:1444–1446
  10. Jungk J, Como-Sabetti K, Stinchfield P, Ackerman P, Harriman K. Epidemiology of methicillin-resistant Staphylococcus aureus at a pediatric healthcare system, 1991-2003. Pediatr Infect Dis J. 2007;26:339–344
  11. Bhattacharya D, Carleton H, Tsai CJ, Baron EJ, Perdreau-Remington F. Differences in clinical and molecular characteristics of skin and soft tissue methicillin-resistant Staphylococcus aureus isolates between two hospitals in northern California. J Clin Micro. 2007;45:1798–1803
  12. Hultén KG, Kaplan SL, Gonzalez BE, Hammerman WA, Lamberth LB, Versalovic J, et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006;25:349–353
  13. Jaggi P, Paule SM, Peterson LR, Tan TQ. Characteristics of Staphylococcus aureus infections, Chicago pediatric hospital. Emerg Infect Dis. 2007;13:311–314
  14. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet. 2005;365:1256–1258
  15. Goering RV, McDougal LK, Fosheim GE, Bonstetter KK, Wolter DJ, Tenover FC. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol. 2007;45:1981–1984
  16. Johnson JK, Khoie T, Shurland S, Kreisel K, Stine OC, Roghmann MC. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg Infect Dis. 2007;13:1195–1200
  17. Han LH, McDougal LK, Gorwitz RJ, Mayer KH, Patel JB, Sennot JM, et al. High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center. J Clin Microbiol. 2007;45:1350–1352
  18. Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza—Louisiana and Georgia, December 2006-January 2007. MMWR. 2007;56:325–329
  19. Chuang YY, Huang YC, Lin TY. Toxic shock syndrome in children; epidemiology pathogenesis and management. Pediatr Drugs. 2005;7:11–25
  20. Buonpane RA, Churchill HRO, Moza B, Sundberg EJ, Peterson ML, Schlievert PM, et al. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med. 2007;13:725–729

PII: S0022-3476(07)00889-X

doi: 10.1016/j.jpeds.2007.09.030

The Journal of Pediatrics
Volume 151, Issue 6 , Pages 561-563 , December 2007